Johnson & Johnson and Intra-Cellular Therapies recently entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra...

Grupa Azoty and Orlen have agreed to continue to work on the terms of a potential transaction whereby Orlen – or another entity designated by Orlen – would acquire all or...

In a move to strengthen its position and product portfolio, Heraeus has announced the acquisition of Umicore's business with platinum-containing active pharmaceutical...

Barentz, a global specialty ingredients provider, recently announced the acquisition of NCD Ingredients, a specialty, personal, and home care ingredients distributor...

IMCD, a global distribution and formulation partner of specialty chemicals and ingredients, has agreed to acquire the personal care and pharmaceutical business of YCAM, a...

In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors.

Ashland recently announced that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first...

As part of its long-term plans in the country, US drugmaker Merck & Co., operating as MSD outside of North America, has acquired WuXi Biologics’ site in Dundalk, Ireland...